In patients undergoing angioplasty for femoropopliteal disease, use of a paclitaxel-eluting rather than an uncoated balloon can reduce late lumen loss and restenosis at 6 months and lessen the need ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results